Integrated Diagnostics Holdings plc (
LON:IDHC -
Get Free Report)'s share price traded down 2.8% on Monday . The stock traded as low as GBX 0.35 ($0.00) and last traded at GBX 0.35 ($0.00). 5,648 shares changed hands during mid-day trading, a decline of 99% from the average session volume of 385,943 shares. The stock had previously closed at GBX 0.36 ($0.00).
Integrated Diagnostics Stock Down 2.8%
The company has a market cap of £10.30 billion, a price-to-earnings ratio of 13.01, a PEG ratio of 7.65 and a beta of 0.59. The business has a fifty day moving average of GBX 0.35 and a two-hundred day moving average of GBX 0.36. The company has a current ratio of 1.59, a quick ratio of 0.75 and a debt-to-equity ratio of 45.72.
About Integrated Diagnostics
(
Get Free Report)
IDH is a leading diagnostics services provider in the Middle East and Africa offering a broad range of clinical pathology and
radiology tests to patients in Egypt, Jordan, Nigeria, Saudi Arabia, and Sudan. The Group's core brands include Al Borg, Al Borg
Scan and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Echo-Lab (Nigeria), Ultralab and Al Mokhtabar Sudan (both in Sudan),
and Biolab KSA (Saudi Arabia).
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Integrated Diagnostics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integrated Diagnostics wasn't on the list.
While Integrated Diagnostics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.